Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Press Room
press_room.png
Filter     Order     Display # 
Date Item Title Hits
14 Aug 2009 Changes ahead in the coagulation factor market by new entrants and technologies 1163
10 Nov 2008 Trends in the diabetes drug pipeline 2008 1078
27 Oct 2008 The future of human insulin: tailored and oral 672
07 Oct 2008 Human growth hormone (hGH): biosimilar pricing is not enough, convenience will mandate 827
10 Sep 2008 Takeda reigns supreme among Japanese pharma companies 751
28 Aug 2008 Emerging diabetes drugs consider beta cell mass and function as an important target 809
12 Aug 2008 The third generation of TPO mimetics are again biologics 902
07 Aug 2008 The changing marketplace of antithrombotics: better than cheaper? 955
23 Jul 2008 Erythropoietins: the shift from biosimilars to “more for less” ESAs 963
28 Mar 2008 Cancer and TNF antibodies boost Biologics Sales in 2007 1249
11 Feb 2008 2008 is a decisive year for the validation of the asthma target interleukin-13 1175
23 Jul 2007 114 Blockbuster Drugs Accounted for 2006 Sales of US$ 233.7 bln 1967
30 May 2007 The imminent change of the antithrombotics market 1617
02 May 2007 Up and down with cholesterol management 1589
25 Apr 2007 Beyond biogenerics: the real threats for therapeutic proteins 2843
15 Mar 2007 La Merie and PharmaPlus team up to provide No-Frills business intelligence solutions 2173
08 Mar 2007 Weight management is not enough for cannabinoid type 1 (CB1) receptor antagonists to become a commercial success 2275
01 Mar 2007 The new class of dipeptidyl peptidase IV (DPP-IV) inhibitors has one clear leader and many followers 1946
26 Feb 2007 TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln 1904
14 Feb 2007 The market of recombinant coagulation factors is growing with next generation products 2137
05 Feb 2007 Dosing convenience is mandatory to keep pace in the pipeline race of GLP-1 analogs for type 2 diabetes 2875
02 Feb 2007 Overview On 2006 Sales Of TOP 20 Biologics To Be Released On February 26 2238
11 Jan 2007 The right balance drives the field of PPAR agonist R&D 2360
19 Sep 2006 Delivery improvements of the AMD-drug Lucentis on the way 2424
07 Sep 2006 Biologics define new standard of therapy in psoriasis 2816
16 Aug 2006 The Crowded Field of VEGF and VEGF-R Targeting Drugs 2597
01 Aug 2006 A Full Pipeline of Follow-on TNF-Antagonists 2704
19 Jun 2006 Biogenerics and new technologies compete with 1st generation major protein products 2480
02 Jun 2006 Imminent launches of new EPO products and consolidation of the biogenerics field 4048
30 May 2006 Localized delivery of PDE-4 inhibitors to open the therapeutic window 2218
 
<< Start < Prev 1 2 Next > End >>
Results 1 - 30 of 46

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

RNA Therapeutics
Order Now

Subscribe La Merie Biologics